Article in Microbiome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
23 authors.
Isaac MartinDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-4828-0369
Mary SilverbergDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-0857-2420
Ahmed AbdelgawadDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-4723-5686
Kosuke TanakaDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-5436-6399
Brian A HalloranDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-4259-4524
Teodora NicolaDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-0815-6785
Erin D MyersCollege of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0003-3939-8995
Jay P DesaiDivision of Neonatology, Department of Pediatrics, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0002-7072-2899
Catrina T WhiteDivision of Neonatology, Department of Pediatrics, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0002-7154-8634
Ibrahim KarabayirDivision of Cardiology, Department of Medicine, Wake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA.ORCID 0000-0002-7928-176X
Oguz AkbilgicDivision of Cardiology, Department of Medicine, Wake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA.ORCID 0000-0003-0313-9254
Laura TiptonDepartments of Biology and Mathematics & Statistics, James Madison University, Harrisonburg, VA, USA.ORCID 0000-0002-5118-2671
Samuel J GentleDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-0238-6472
Namasivayam AmbalavananDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-0731-9092
Brian M PetersDepartment of Clinical Pharmacy and Translational Science, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0002-0445-2077
Luan D VuDepartment of Molecular Microbiology and Immunology, The University of Texas at San Antonio, San Antonio, TX, USA.ORCID 0000-0001-8493-1811
Viral G JainDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-1897-6461
Charitharth V LalDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-9071-4047
Stephania A CormierDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA, USA.ORCID 0000-0002-6050-6172
Joseph F PierreDepartment of Nutritional Sciences, College of Agricultural and Life Sciences, The University of WI-Madison, Madison, WI, USA.ORCID 0000-0002-4248-1290
Tamás JillingDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-6200-3851
Ajay J Talati *Division of Neonatology, Department of Pediatrics, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0002-7980-3679
Kent A Willis *Division of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA. kawillis@uab.edu.ORCID 0000-0001-7338-0399
Funding
DEEP SOUTH TRANSLATIONAL RESEARCH MENTORED CAREER DEVELOPMENT PROGRAMKL2TR003097 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2019 to 2023
$5.2M
Role of microbial-modulated bile acid receptor signaling in breast cancerR01CA253329 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Katherine Loree Cook, Liza Makowski-Hayes · 2020 to 2026
$3.0M
Candidalysin: a key mediator of Candida vaginitis immunopathologyR01AI134796 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Brian M Peters · 2018 to 2026
$2.9M
Let-7b in BPDR01HL156275 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Namasivayam Ambalavanan · 2023 to 2026
$2.2M
STOP BPDR01HL129907 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMBALAVANAN, NAMASIVAYAM · 2015 to 2017
$1.1M
The gut-lung axis influences the development of bronchopulmonary dysplasiaK08HL151907 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIS, KENT AVERY · 2020 to 2024
$854k
Mechanisms of Pulmonary Microbiota-Induced Inflammation and Vascular Dysfunction in Neonatal Lung InjuryK08HL141652 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAL, CHARITHARTH VIVEK · 2019 to 2023
$838k
Modeling Host-Fungal Interactions in Hirschsprung-Associated EnterocolitisR21AI163503 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI GOSAIN, ANKUSH, PIERRE, JOSEPH F · 2021 to 2022
$441k
Oral nitrate metabolism as a predictor for bronchopulmonary in preterm infantsR21HD100917 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GENTLE, SAMUEL J, PATEL, RAKESH P. · 2020 to 2021
backgroundThe immature lungs of very preterm infants are exposed to supraphysiologic oxygen, contributing to bronchopulmonary dysplasia (BPD), a chronic lung disease that is the most common morbidity of prematurity. While the microbiota significantly influences neonatal health, the relationship between the intestinal microbiome, particularly micro-eukaryotic members such as fungi and yeast, and lung injury severity in newborns remains unknown.
resultsHere, we show that the fungal microbiota modulates hyperoxia-induced lung injury severity in very low birth weight premature infants and preclinical pseudohumanized and altered fungal colonization mouse models. Instead of fungal communities dominated by Candida and Saccharomyces, the first stool microbiomes of infants who developed BPD had less interconnected community architectures with a greater diversity of rarer fungi. After using a pseudohumanized model to show that transfer to the neonatal microbiome from infants with BPD increased the severity of lung injury, we used gain and loss of function approaches to demonstrate that modulating the extent of initial neonatal fungal colonization affected the extent of BPD-like lung injury in mice. We also identified alterations in the murine intestinal microbiome and transcriptome associated with augmented lung injury.
conclusionsThese findings demonstrate that features of the initial intestinal fungal microbiome are associated with the later development of BPD in premature neonates and exert a microbiome-driven effect that is transferable and modifiable in murine models, which suggests both causality and a potential therapeutic strategy. Video Abstract.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The fungal microbiota modulate neonatal oxygen-induced lung injury. · full record | OpenQuestion